Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants

BACKGROUND: The high cost of pneumococcal conjugate vaccine (PCV) and local epidemiological factors contributed to evaluating different PCV dosing-schedules. This study evaluated the immunogenicity of seven-valent PCV (PCV7) administered at 6-weeks; 14-weeks and 9-months of age. METHODS: 250 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Stephanie A., Groome, Michelle, Koen, Anthonet, Van Niekerk, Nadia, Sewraj, Poonam, Kuwanda, Locadiah, Izu, Alane, Adrian, Peter V., Madhi, Shabir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755982/
https://www.ncbi.nlm.nih.gov/pubmed/24015277
http://dx.doi.org/10.1371/journal.pone.0072794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755982/
https://www.ncbi.nlm.nih.gov/pubmed/24015277
http://dx.doi.org/10.1371/journal.pone.0072794

Ejemplares similares